Women can wait years for an endometriosis diagnosis. New tech could change that

Women can wait years for an endometriosis – Endometriosis often remains undetected for years in many women, according to recent findings. A breakthrough in diagnostic imaging, developed during a pilot study at Oxford University, offers hope for earlier identification of the condition, potentially reducing the time it takes to receive a correct diagnosis. This innovation, which combines CT scans with a specialized molecular agent, aims to detect early-stage endometriosis, a challenge that has long plagued conventional methods.

The New Diagnostic Approach

The technique employs computed tomography (CT) scans alongside a molecular tracer named maraciclatide. This agent binds to areas where new blood vessels develop, a hallmark of early endometriosis growth. By highlighting these vascular changes, the method may uncover the disease more effectively than traditional imaging, which typically focuses on visible abnormalities. Dr. Tatjana Gibbons, the lead researcher on the study, highlights that current scans often fail to identify early-stage cases, leading to repeated tests and prolonged uncertainty for patients.

“This indicates that many women endure discomfort even after receiving normal imaging reports,” Dr. Gibbons explains. “Early detection can empower individuals to make informed choices about their health and future.”

The study involved 19 participants with suspected or confirmed endometriosis. Of these, the technique accurately identified the presence or absence of the condition in 16 women and correctly flagged 14 out of 17 confirmed cases through subsequent surgical verification. These results suggest a promising new way to diagnose the disease without invasive procedures, which can be both time-consuming and uncomfortable.

Personal Impact of Delayed Diagnosis

For Gabriella Pearson, a 33-year-old co-founder of the Menstrual Health Project charity, the journey to diagnosis was a decade-long struggle. Diagnosed at age 23 after years of worsening symptoms, she recalls being told her periods were “normal” and her pain was simply “part of being a woman.” Misdiagnoses with conditions like irritable bowel syndrome or stress delayed her understanding of her condition, leaving her unable to pursue her career or attend university. “I wasn’t able to progress with my life due to the pain and complications,” she says.

“If I had been diagnosed earlier, I would be in a much better position today,” Pearson emphasizes. “There are significant consequences to waiting—mental health, financial strain, career setbacks, and fertility challenges. Early detection could transform people’s quality of life.”

Pearson’s experience is not unique. Many women report feeling isolated by their symptoms, which can include severe menstrual pain, fatigue, and gastrointestinal issues. The lack of a reliable, non-invasive diagnostic method often forces patients to undergo multiple tests, including ultrasounds and MRIs, before a definitive answer is reached. Laparoscopy, the current gold standard for diagnosis, requires a small abdominal incision and a camera to visually inspect for endometriosis lesions. While effective, this procedure is invasive and may take years to schedule, exacerbating the delay in treatment.

Research Findings and Future Potential

Dr. Gibbons describes the study’s results as “exciting,” noting that the new technique could serve as a valuable diagnostic and monitoring tool. She specifically mentions superficial peritoneal endometriosis, a common yet difficult-to-identify form of the disease, as a potential target for this method. “This could be a game-changer for women experiencing symptoms that are often overlooked,” she adds.

“There’s an urgent need for non-invasive imaging techniques,” says Dr. Lucy Whitaker, a gynaecologist and researcher at the University of Edinburgh. “This preliminary data opens the door to earlier intervention and treatment, which is critical for managing the disease’s impact.”

The technique’s success in identifying early-stage endometriosis may have broader implications. It could allow doctors to track disease progression over time and assess how different factors, such as lifestyle or medication, influence its development. For Pearson, the hope is that such advancements will not only ease the diagnostic process but also reduce the physical and emotional toll on patients. “A non-invasive scan that consistently captures the disease’s signs would make a huge difference,” she says.

Challenges and Next Steps

Despite the encouraging results, the method is still in the early stages of development. Dr. Gibbons acknowledges that further research is needed to validate its effectiveness across larger patient groups. However, the potential to replace or complement current diagnostic practices could be transformative. “If this technique proves reliable, it could eliminate the need for unnecessary invasive procedures and provide quicker, clearer answers,” she notes.

Endometriosis affects approximately one in ten women in the UK, with symptoms ranging from heavy menstrual bleeding to chronic pelvic pain. Its complexity often leads to confusion with other conditions, creating a cycle of misdiagnosis and delayed care. Pearson’s story underscores this issue: her debilitating periods began at age 10, and over the next six years, she bounced between doctors, receiving contradictory explanations. It wasn’t until she found a general practitioner who suspected endometriosis that she finally got a diagnosis.

While the new technology represents a significant step forward, it’s essential to address the broader challenges of endometriosis management. Early detection not only alleviates suffering but also improves treatment outcomes, as the disease is more responsive to intervention in its initial stages. The research team at Oxford University is optimistic about the technique’s future, with Dr. Gibbons stating, “This could be a turning point for women who have waited years for a diagnosis.”

For Gabriella Pearson, the dream of a reliable, non-invasive test is more than scientific—it’s personal. “I’ve endured an invasive ultrasound that was painful and inconsistent,” she recalls. “A scan that’s both accurate and gentle would make all the difference for patients like me.” As the study moves forward, its success could pave the way for a new era in endometriosis care, offering women a faster, more precise path to understanding their health. This development, if confirmed by larger trials, may finally provide the clarity and support that countless women have waited for.